New research into retatrutide, a dual agonist for GLP-1 and GIP receptors, are showing promising outcomes in treating weight gain and diabetes non-insulin-dependent condition. Animal evidence suggest a unique action https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/